All News

Found 3,878 articles

• ImmunoGen, Inc. Reports First Quarter Fiscal Year 2014 Financial Results and Provides Quarterly Update

  10/25/2013

• ImmunoGen, Inc. Reports on Additions to Its Industry-Leading ADC Technology Portfolio at ImmunoGen, Inc.-National Cancer Institute-EORTC Conference

  10/23/2013

• Mersana Therapeutics, Inc. Forms Scientific Advisory Board to Support Development of Next-Generation Antibody-Drug Conjugates

  10/21/2013

• ImmunoGen, Inc. Announces SAR566658 Clinical Findings Reported at American Association for Cancer Research-National Cancer Institute-EORTC Conference

  10/21/2013

• ImmunoGen, Inc. Announces Conference Call to Discuss its First Quarter Fiscal Year 2014 Financial Results

  10/18/2013

• Soricimed Biopharma, Inc. Shows Promise in Treating Breast and Ovarian Cancer

  10/16/2013

• Sutro Biopharma Presents Dual-Warhead Antibody Drug Conjugate at the World ADC Summit

  10/16/2013

• AstraZeneca PLC's MedImmune Takes Over Spirogen Ltd. for Up to $400 Million to Bolster Oncolology Portfolio

  10/15/2013

• Mersana Therapeutics, Inc. Earns Milestone Payment in Fleximer-ADC Collaboration With Endo Pharmaceuticals

  10/15/2013

• Sorrento Therapeutics, Inc. Acquires Clinical Stage Drug Candidate for Treatment of Chronic Pain

  10/11/2013

• ImmunoGen, Inc., Novartis AG Announce New License Agreement

  10/11/2013

• Molecular Templates Inc. Announces $8.5 Million Series C Financing and $10.6 Million Grant Funding

  10/8/2013

• CPhI Annual Expert Industry Report: Part I

  10/2/2013

• ImmunoGen, Inc. Announces Results from Kadcyla® Phase III Trial, TH3RESA, Being Presented Today at the European Cancer Congress

  9/30/2013

• ImmunoGen, Inc. Announces Positive Regulatory Decisions for Roche's Kadcyla® in the European Union and Japan

  9/20/2013

• Sorrento Therapeutics, Inc. Announces a Presentation on Cynviloq&#0153 at the AACR Conference on Advances in Ovarian Cancer Research: From Concept to Clinic

  9/16/2013

• Sorrento Therapeutics, Inc. Completes IgDraSol Merger

  9/10/2013

• Sorrento Therapeutics, Inc. Secures Rights to Biomiga Diagnostics' Therapeutic Drug Monitoring Device for Development of Personalized Paclitaxel Cancer Therapy

  9/10/2013

• Sorrento Therapeutics, Inc. to Present at Two Healthcare Conferences

  9/6/2013

• ImmunoGen, Inc. Announces Webcast of Presentations at Upcoming Investor Conferences

  9/4/2013